Table 3_Prognostic value of systemic inflammation response index in successfully recanaliz

A dual-center retrospective study from Zhejiang, China, investigates the prognostic value of the Systemic Inflammation Response Index (SIRI) in stroke patients. It includes 287 successfully recanalized acute large vessel occlusion stroke patients who underwent endovascular therapy. The dataset, authored by Wangyu Zhang and last updated in May 2026, likely contains patient-level clinical and outcome data.

Use Cases

• Predicting 90-day functional outcomes based on baseline SIRI levels.
• Evaluating the incremental predictive value of SIRI when added to models using age and NIHSS scores.
• Investigating associations between inflammatory biomarkers and hemorrhagic transformation.
• Training logistic regression models for binary classification of stroke patient outcomes.

Strengths

• Includes 287 patient records from two stroke centers.
• Provides specific statistical results, including ROC AUC values (e.g., 0.63 for SIRI) and model improvement metrics (ΔAUC=0.035).
• Reports detailed patient demographics (mean age 70.9 years, 58.5% male).

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Data may reflect geographic bias inherent to the two centers in Zhejiang, China.

Provenance

Source

figshare

Collection Method

Retrospective study of patient records from two stroke centers.

Freshness

Last updated 2026-05-28 04:52:57; freshness should be verified.

Geography

Zhejiang, China